Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04048200Phase 4Completed
Phase 4, randomised, double-blind trial of dexmedetomidine and ketamine in class III obesity (2 arms), sponsored by Tanta University. Primary endpoint: Postoperative opioid consumption at 24 hours. Started Sep 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04048200.